Point of prostate cancer diagnosis experiences and needs of black men: the Florida CaPCaS study A s of 2016, Florida ranks second among all states in the United States in estimated new cases of prostate cancer and second in estimated deaths from prostate cancer. 1 Disparities in diagnosis, mortality rates, and access to cancer care also continue to be a major problem in Florida, especially for black men. For example, black men were the only racial/ethnic group that did not meet the Healthy People (HP) 2010 objective to reduce the prostate cancer death rate to 28.2 per 100,000 men and that has not met the HP 2020 objective to reduce the prostate cancer death rate to 21.2 per 100,000 men (Table 1) . Based on the 2013 prostate cancer mortality rates for Florida, 2 the death rate for black men is almost twice the HP 2020 goal (37.49 per 100,000).
A diagnosis of prostate cancer is a life changing event for a man. In particular, there is limited research on the experiences and coping mechanisms of black men at diagnosis. This limited body of research indicates that black men's reactions to their initial diagnoses varied, from being shocked when notified of their initial diagnosis of prostate cancer, 3 to perceiving that they had received a "death sentence". 4 In regard to having to make decisions about their treatment options, some black men indicated that the information about treatment that they received from physicians decreased their anxiet y, 5 whereas others noted that they had not been given adequate information by a physician to make a decision. 6 Patients have also reported that they felt as though they were not knowledgeable enough to ask questions concerning treatment options and preferred for the physician to make the treatment Background Black men are disproportionately affected by prostate cancer and little is known about their experiences at the point of prostate cancer diagnosis (PPCD). Men who self-identify as black are commonly treated in a singular cohort even though they may be of diverse ethnic origin. This is especially important given the increasing number of foreign-born blacks in the United States. Objective To examine the experiences and needs of ethnically diverse black men at the PPCD to develop an interpretative framework. Method The research population was black men who had been diagnosed with prostate cancer during 2006-2010. We used a qualitative research design based on grounded theory principles. Using a semistructured interview guide, a trained interviewer collected data on the participants' PPCD experiences. The data analyses included verifying the narrative data, coding data, and developing an interpretative framework.
Results From an initial sample of 212 black men, data were collected from 31 participants. The interpretative framework that emerged from the study describes the status of black men at the PPCD, experiences of black men at the PPCD, and emotional reactions of black men at the PPCD. Of note is the need among men at the PPCD for psycho-oncology support, emotional support, and time to reflect on the diagnosis. Limitations Men with different experiences may have chosen not to respond to recruitment efforts or refused participation in the study. Conclusion The framework provides information that physicians can use to help their patients cope at the PPCD. It is important to understand these men's needs and help them cope effectively as they navigate the survivorship continuum. In line with our research program's goal of ensuring quality cancer care for black men, the primary objective of this study was to explore the experiences and needs of black men at the point of prostate cancer diagnosis (PPCD). Specifically, we developed an interpretative framework for black men's experiences at the PPCD, focusing on United States or native-born black men (NBBM) and Caribbeanborn black men (CBBM). African-born black men were not included in this study because of the low sample size for that ethnicity. This study is part of a large-scale study that focuses on developing a model of prostate cancer care and survivorship (CaPCaS model) using grounded theory to study black, ethnically diverse prostate cancer survivors.
Methods
The study aims to close the prostate health disparity gap for black men in Florida through community engaged research in partnership with survivors of prostate cancer and their advocates. The current study was a prospective, grounded theory study that involved one-on-one, in-depth interviews with 31 prostate cancer patients about their care and survivorship experiences. Specifically, 17 NBBM and 14 CBBM were enrolled in the project. Appropriate human subjects review and approval were obtained from the University of Florida, the Florida Department of Health, and the Department of Defense.
Research design
This is a qualitative research study. Based on the principles of community engaged research and using a rigorous qualitative research methodology, we recruited NBBM and CBBM with a personal history of prostate cancer. Guided by openended questions developed by the team, one-on-one indepth interviews were conducted with each participant in their home or at a convenient location in the community. Our primary focus was on the participants' care and survivorship experiences, with primary focus on their prostate cancer diagnosis. Qualitative research was our methodology of choice because little is known about the PPCD experiences of black men. 8 With qualitative research, we were able to get our participants to "relive" their experiences in the presence of a culturally competent, well-trained interviewer and elicit the information about their care and survivorship experiences based on their interpretation. In addition, we were able to capture the dynamic processes associated with their experiences, documenting sequential patterns and change through both verbal and nonverbal communications, because the participants were interviewed twice.
Research population and recruitment
The study setting was Florida. The inclusion criteria were: black men, personal history of prostate cancer, ability to complete two separate interviews with each one expected to last 2-3 hours, and flexibility to meet interviewers at a convenient community site for the interviews. Participants were identified through the Florida Cancer Data System (FCDS) 9 database. At the time of the study, the most recent FCDS database was for 2010. The FCDS has collected the number of new cancer cancers diagnosed in the state of Florida annually since 1981. It is a comprehensive incidence-only registry and does not extract data on patients with a death certificate. All investigators are bounded by the confidential pledge required for the use of the FCDS data.
We used the Florida Department of Health's (DoH's) Bureau of Epidemiology standard procedure for the FCDS 9 to recruit participants. Our recruitment strategies included: initial patient contact by written correspondence; second mailing that included a telephone opt-out card after 3 weeks for nonrespondents (the telephone opt-out card explained to the patient that if no response was received, the study investigator would attempt a telephone call to introduce the study); and a telephone call by a study staff to introduce the study for nonrespondents. As per the Florida DoH standard procedure, we did not disclose on the cover of the study mailings that the patient was being contacted for a study specific to cancer. Efforts to recruit a patient stopped immediately if a patient indicated that he did not wish to participate. All of the study staff making participant contact were extensively trained to provide a clear and accurate description of cancer registration in Florida. In addition, to assist the study staff in providing clear and accurate responses, responses to frequently asked questions were made available to the study staff. During the participant recruitment phase, anyone who seemed to be upset when contacted was reported immedi- ately (within 24 hours) to the DoH cancer epidemiologist. In addition, the name of anyone who stated that he did not wish to be contacted again was given to the DoH so that the person would not be re-contacted.
Prescreening of participants for eligibility
All eligible participants who agreed to participate in the study comprised the pool of potential study participants.
For those who agreed to participate, the following information was obtained by telephone interview using REDCap software: 10 name and contact information, country of birth, age, marital status, and education level. The demographic information facilitated a purposeful systematic selection of black men of diverse age groups (younger than 50 years or older than 50 years), marital status (single, including divorced or separated, or married/in a relationship), and educational level (college degree or not college educated). An incentive of a $5 gift card was provided to all the men who participated in the screening phase. Using systematic sampling to ensure demographically diverse participants, 40 participants (20 NBBM, 20 CBBM) were selected from the initial pool of participants to participate in the study.
Data collection
The data collection was conducted by a trained Community Health Worker (CHW) using semi-structured interview process. The interview guide was constructed by the research team and the study community advisory board members to ensure language appropriateness, understanding and cultural sensitivity. For this study, the interview questions focused on participants' background information and diagnosis history, including: participants' personal story of diagnosis, feelings, emotions, reactions, regrets and level of personal/family/ physician involvement in diagnosis. For the CBBM, we also obtained information on the age at which they immigrated to the United States. The CHW interviewer was trained to question participants and encourage them to elaborate on areas of importance to their experience.
A total time of about 5-6 hours was scheduled for the data collection per participant, which is sufficient for gathering in-depth perspectives. We scheduled two interviews lasting not more than 3 hours at a time so as not to create burden for study participants. Participants had the choice to have the interviews completed in a single session or spread out over 2 days. The interviews were audio-recorded to provide ease of transcription and back-up of data. At the end of the interviews, participants were compensated for participating in the study.
Data management and analyses
The study dataset included interview transcripts and field notes of the CHW interviewer describing his insights about the interviews. The data analyses included preparing and verifying the narrative data, coding data, and developing an interpretative framework for black men's experiences at the PPCD. Interviews were transcribed verbatim by a professional transcription service that has policies in place for protected health information. Each transcript was then verified for accuracy by the CHW interviewer. The interview transcripts were imported directly into NVivo 11, a computer-assisted data analysis software that allows coding and modeling of complex narrative data. The data coding was conducted by our interdisciplinary team of clinicians, behavioral scientists, and social scientists. It is important to note that the NVivo 11 software was not used to analyze the data per se. However, it provided a sophisticated and systematic way to manage the following tasks for the analyses: organizing large quantities of narrative data, coding text, retrieving text by codes, querying the data, comparing sets of data interpretation between NBBM and CBBM; and developing analytic models. The study team members coded the data in weekly team meetings. The coding consisted of reading the data and identifying major themes, then assigning labels to and defining emerging categories.
Two levels of coding were used. The first, open coding, refers to an approach to data with no preconceived ideas about what will be found; and the second, focused or axial coding, refers to reviewing data for the purpose of more richly coding on a particular theme. 11 We used dimensional analysis to ensure that each emerging concept was carefully defined. The study team went back and forth between the data and the emerging analytic framework, using constant comparison of new data with already coded data and new categories with previously analyzed text. 12 To ensure trustworthiness and credibility, 13 the study team maintained an audit trail that documented how and when analytic decisions were made. In addition, peer debriefing was conducted to ensure credibility, including the presentation of findings to the study community advisory board members as part of the community engaged research approach.
Results

Description of participants
The FCDS provided a database of 1,813 participants identified as black men diagnosed with prostate cancer in 2010. Because the FCDS does not extract data on patients with a death certificate, we found out during the pre-screening phase that a few of the men were deceased. In addition, there were a significant number of incorrect addresses. We obtained a total of 212 completed responses by phone during the prescreening phase. The majority of the participants were aged 60-69 years (48.2%), had a high school diploma only (26.1%), and were currently married (65.3%). Relative to ethnicity, 67% of participants classified themselves NBBM, 24% as CBBM, 3.5% as black men born in Africa, and 5.5% as Other/Don't know/Refused. For the CBBM, the most common countries of birth were Jamaica, Haiti, and Guyana, respectively.
In all, 40 participants (20 NBBM and 20 CBBM) were selected from the 212 participants to participate in the study. Selection was conducted systematically to ensure representation in terms of age, marital status, education, and geographical location. Data saturation was achieved with 17 NBBM and 14 CBBM, after which we ended data collection (Table  2 ). Data saturation is the standard for deciding that we are not fi nding anything diff erent from the interviews fi rst coded and last coded. Although we were specifi cally looking for diff erences between the two groups (NBBM and CBBM), no between-group diff erences emerged. Each man's experience was unique to him with some common themes emerging described hereinafter (Figure) .
Moderating factors and experiences at PPCD
Some of the moderating factors that the study participants identifi ed as aff ecting their reactions to the PPCD included health literacy, insurance status, spirituality, mistrust, prior experience with cancer, perceived susceptibility to cancer, and delay in diagnosis (Table 3 , p. 15). Health literacy, defi ned as personal, cognitive, and social skills that determine the ability of individuals to gain access to, understand, and use information to promote and maintain good health, was one of the moderating factors found in this study. 13 Some of the black men came to the PPCD with a low level of health literacy, which had an impact on their understanding of the treatment options. For example, in the interview, participant 798 (NBBM) was confused about what tests had been done and was not able to accurately describe the treatments off ered to him. Participant 1263 (CBBM) struggled to express the purpose and procedures associated with diagnostic biopsy. However, there were participants with a high level of health literacy (eg, participant 449 [NBBM]), who decided to research the disease.
Another factor to consider is the insurance status of participants at the PPCD. Th e majority of the participants had good insurance coverage, but some were aff ected by poor insurance coverage. Participant 1881(NBBM) made his treatment decision primarily on the basis of the pending lapse of his insurance coverage rather than the best clinical option for him. Participant 1979 (CBBM) described both his confusion on the screening tests and the impact of not having insurance coverage. Upon obtaining insurance coverage, he sought treatment for his prostate cancer with an urgency that he did not experience when he was fi rst diagnosed when uninsured.
Th e spirituality of black men was another moderating factor at the PPCD. Participant 827 (NBBM) noted that he was unaff ected when he received his diagnosis because he was a true believer. Some of the black men also came to the PPCD with lack of trust in the physician and/or the health care system and perceived a sense of contempt from the physician. Participant 1594 (NBBM) described mistrust based on the history of medical exploitation of black men as well as a perception of current discriminatory practices.
Another important PPCD status to note for black men is prior experience with cancer, including prior personal cancer history and/or prior cancer history of a family member. Participant 2024 (CBBM) described the meaning of cancer to him, while participant 798 (NBBM) echoed the despair of the cancer diagnosis based on experience with other cancers in the family. Sometimes there were multiple cancers in the family or even among the signifi cant others of the participant, as was the case with Participant 1936 (CBBM).
Of greatest concern were men who delayed their diagnosis or treatment, perhaps resulting in their cancer being at a more advanced stage when they eventually did return for care. Finally, some of the men came to the PPCD appointment with a low expectation of receiving a diagnosis of prostate cancer, whereas others came to the PPCD fearful of the results of their testing.
In describing their experiences, participants expressed both positive and negative experiences: on the positive side, they found the information provided by the physician to be helpful; but on the negative side, the sterile or medicallyfocused encounter was perceived as a lack empathy on the part of the physician.
Cognitive, emotional, and behavioral coping experiences As expected, there were ranges of emotions, including shock, disbelief and denial (Table 4 , p. 17). Some of the men questioned why this (the cancer) was happening to them when they had done "nothing" to deserve it. Doing nothing in this case meant that they had lived a healthy lifestyle with no obvious apparent cause to have the cancer. Fear and cancer fatalism were experienced by a significant number of the men, with their thoughts immediately turning to death and dying. This was especially the case for men who had lost a loved one to cancer. Conversely, some of the men wanted immediate resolution, focusing instead on ways to beat the cancer and with a strong will to live. Reliance on faith was a big part of coping at the PPCD. Some of the men drew strength from their faith to get them through their cancer journey. Others found a way to accept the diagnosis -one participant accepted the diagnosis and the fact that this could mean dying (after living a good life), whereas another participant accepted the diagnosis with the hope that he would find a cure. Hope was more realistic with the knowledge that other men had survived prostate cancer.
Reflecting back on their experiences, the men also identified clear needs at the PPCD. One of the needs they identified was having a physician they were comfortable with to discuss their diagnosis. Another need was for a second opinion. Participant 1594 (NBBM) advised that it was important for black men to take control by requesting a second opinion. Participant 2039 (NBBM) described a feeling of navigating blindly and trying to find answers that would be helpful to him in his cancer journey. However, his experience with a second opinion was not helpful because the second physician was at the same clinic as his primary physician. His recommendation was to get a second opinion at a different clinic or center. Another important need was emotional support at the PPCD. Participant 2024 (CBBM) made a strong case for emotional support, especially for men who are not accompanied during diagnosis. In addition, Participant 2024's (CBBM) reflections underscore the fact that the PPCD may not be an ideal place or time to discuss treatment options. With the range of emotions that the men go through at the PPCD, it is difficult to comprehend any follow-up discussions after hearing the words "you have prostate cancer." Participant 2024 (CBBM) also strongly expressed that men need time to deal with the diagnosis at the PPCD.
Discussion
The primary goal of this study was to develop an interpretative framework of black men's experiences at the PPCD. The Figure provides a pictorial summary of the framework. Study results indicated that black men come to the PPCD with different emotions and different experiences. Although the majority of the men were NBBM, there is a significantly increasing number of foreign-born black men receiving a diagnosis of prostate cancer in the United States. Given that black men carry a disproportionate burden of the disease, with a significantly higher incidence compared with any other racial group, it is important that tailored services are provided to black men at the PPCD.
We also found that black men came to the PPCD diverse in terms of their ethnicity, health literacy, spirituality, trust in health care system/physician, prior experience with cancer, perceived susceptibility to cancer, delayed time for diagnosis, and fear of diagnosis. Of importance for physicians is that the black race is not homogeneous. There is a significant number of foreign-born blacks at the PPCD, and they often have different cultural beliefs and values compared with NBBM. In addition, some of the foreignborn black men may not have English proficiency and may need a medical interpreter during the PPCD consultation. In addition, a patient's pre-existing lack of trust in the 
Health literacy
Participant 798 (NBBM) Yeah, yeah. We, uh-I had-I had-I had two-I had two, uh-the options they gave methey could go-they could do a-uh, like a surgery-… and, uh-and they could do a-a-a-wow, man. I can't pronounce these big words. Uh, it's somethin' like a bop-bop-mmm. Well, anyway, it was between the surgery and, uh, the-the blaze-the blaze. It was, uh-it was-what you call it? It's, uh-it was a blazer treatment. It was like a-a blazer where you get-it's just-just what-they set-they lay you on this table, and then they turn this big machine, you know, and it go across your body ….Then it come back around cross your body, and then-then when they do that, then you get up. It's just like a blazer that goin' in there cuttin', you know, or-or burnin' the cells in-inside you.
Participant 1263 (CBBM) They find out, my last test I have is when I have the um, the bionic shot. The 12 shots …. Yeah, 12 shots. That's-that shot is just like a test to you, they put the full light on, put you to sleep if you want to sleep, if you don't want to sleep the camera up in your bomsee and then it tests your 12 shots and send to test and come backfour come back positive, and the rest then came back normal …. The four positive was aggressive.
Participant 449 (NBBM) I can say that for sure, and probably with my father as well. The reason that I started, um, monitoring my PSA was because, uh, my father finally talked to me about his prostate cancer. I did some research on it, and one of the first things that I, uh, read was that prostate cancer could be hereditary. With that in mind, I decided that I needed to do something to make sure that if I was going to get prostate cancer, that I knew about it as soon as possible.
Insurance status Participant 1881(NBBM) And I think-but I was guided-I think I was led that way by-by options that were not viable, that were not given to me with the-once again, it was the policy beginning to lapse, not bein' renewed, not knowin' whether or not I'm gonna be able to get insurance to-to follow through on that. And so there's an urgency situation here as well. I gotta get up under this before that policy lapse and get this done.
Participant 1979 (CBBM)
Uh, I learned, uh, eh, I had prostate cancer-when I get prostate cancer, and I-uh, no. First time, before, I don't-I don't have, uh, insurance. I go to the clinic that gives me-they put me in their program, but the doctor one day told me, "_______, you're supposed to make a test, a digital test."... its name PCS-S-PSA, I think so-to check if you, uh, negative about that, but I scared because I know on the first time they do that for me, eh, I don't like it. 
Mistrust
Participant 1594 (NBBM) And as black men-and I think one-and I can attest to this-we don't trust doctors because of the Tuskegee experiment and other things that they do …. They are sometimes-uh, white doctors, they look down or they don't want to touch you. And just, um, to point that out.
Prior experience Participant 2024 (CBBM) Because, um, although I knew that prostate cancer, um, had the best chance of being cured of all the cancers, when the doctor told me I had prostate cancer, I did not hear prostate, I heard cancer. The big C. And my brother, um, my younger brother died, um, back in 2006 from, um, colon cancer, so that was-it was that close to me because I was diagnosed most about five years ago. So it was that close to me, the memory of him, I only heard cancer.
Participant 798 (NBBM)
First thing that came to my mind there, I said, "Oh, Lord, don't tell me that I got cancer." And I'm-I'm just seein' one of, my sister just died with cancer. And it just-the thing that started runnin' through my mind, the people I know that died with cancer, and I'm sayin', "Don't tell me I got this here." You know? And I-you know, and, uh-and I didn't never see, you know, uh-like, I wasn't never there, but I never seen nobody tell me they went to the doctor and all this here, and I said, "I don't wanna-I don't wanna be caught up in like that."
Participant 1936 (CBBM) I mean, I was-I-I just was thinkin' of my dad and thinkin' of-um, well, at the time I had a-um, a fiancée. She also passed with-um, um, with cancer, was the-uh, I forget the one that what it's call, but she had that, you know. Then I also thought of my mom. My mom passed away with lung cancer in-uh, in her 90s.
Participant 329 (NBBM)
Here we go again. No, I-the-the process of having cancer.
Perceived susceptibility
Participant 2039 (NBBM) Prior to that-to-prior to that prostate cancer was foreign to me. It-it was somethin' that happens to everybody else and not me.
Delay in diagnosis or treatment
Participant 915 (NBBM) You know? Not like swollen. It just felt rough or somethin', I guess. Um, a year later he checked it again and said, you know, "It just feels strange." He'd like to take a picture of it. And then they took pictures, and he saw, uh, where it was discolored and, you know, deformed, and thought that it was cancerous.
Continued on next page
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Fearful of testing
Participant 847 (NBBM) Well, it was just-I guess it-it was about-it was time for me to get a check-up. I had been putting it off and was scared, and so I said, "Well, I'm getting pretty old and I need to go in and get this checked." And that's how I-that's how it came about. And-and um-
Experiences at PPCD
Participant 449 (NBBM) Um, based on, uh, the information that, uh, the doctor shared with me, I-I-I thought thethe diagnosis was accurate. Um, I didn't really have any, um, other questions that he or the staff could answer that they didn't answer. They were pretty-pretty thorough in answering most of my questions.
Participant 1594 (NBBM) But I finally went to the, um-they got me a room where I could wait on the doctor. I sat there, and the lights was dim. I guess that's to make you relax. Uh, but one thing that was most disturbing to me was when the doctor came in the room. He just asked me when was I ready-what treatment I wanted. And I looked at him crazy cuz he had not identified himself. He hadn't said good morning. And I said, "Look. Let me think on this." I said, "Cuz you haven't said good morning or nothing. You're just asking me when I want to start the treatment." I came, went back to the car, and I knew I had to do something. So I said, I need to talk to someone.
CBBM, Caribbean-born black man; NBBM, native-born black man; PPCD, point of prostate cancer diagnosis.
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health care system may have a negative impact on the PPCD consultation. It is thus important that the physician takes the time to instill trust and make the men comfortable during the PPCD consultation. For some of the men who had fear of a prostate cancer diagnosis and/or prior experience with cancer, cancer fatalism was experienced at the PPCD. Cancer fatalism, defined as an individual's belief that death is bound to happen when diagnosed with cancer, has been documented as a major barrier to cancer detection and control. 15 For example, fatalistic perspectives have been reported to affect cervical cancer, 16 breast cancer, 17,18 colorectal cancer, 19 and prostate cancer 20,21 among blacks. It is thus important to effectively address fatalistic beliefs when a man is diagnosed with prostate cancer.
Other emotions at the PPCD that may affect effective treatment decision making also need to be addressed immediately. For example, the emotions of fear, denial, and feeling overwhelmed are potential barriers to timely treatment decision making. Psycho-oncology interventions to appropriately deal with these emotions at PPCD or right after the diagnosis may be crucial for the men. In particular, a group-based psychosocial intervention focusing on: provision of education about treatment options for prostate cancer and their acute and late effects; negotiating treatment and treatment side effects; enhancing communication with treatment providers; managing distress; and engaging positive family-and community-based social support to optimize emotional, behavioral, social, and physical outcomes in black men with prostate cancer.
In addition to having physicians make them comfortable at PPCD, the PPCD needs expressed by participants included having time to come to terms with the diagnosis and receiving psycho-oncology/emotional support. Anyone who has just received a diagnosis of cancer cannot be expected to immediately continue to function as he did before the PPCD. This is especially difficult for men who are alone at the PPCD. Nevertheless, it is expected that they will listen attentively and understand subsequent consultation by the physician, then leave the consultation room almost immediately, and be able drive home or back to work right after the diagnosis. There seems to be a support gap that needs to be closed at the PPCD. Providing the men with immediate support to cope with the diagnosis may make a significant difference in effective treatment choices and eliminating treatment decisional regrets.
Methodological rigor was established through purposeful sampling, extended time with participants, standardized procedures for data collection, management and analysis, multidisciplinary interpretation, and validation of results with the community advisory board. Because the research participants were purposefully selected from a statewide database of black men diagnosed with CaP, generalizability of findings to the two target groups of NBBM and CBBM can be assumed, with the caveat that men with different experiences may have chosen not to respond to recruitment efforts or refused participation. Black men who were not sufficiently fluent in English to be interviewed were also excluded and are not represented in these findings. Black men of other nativity (including African-born black men) and residing outside of Florida were also not represented.
In conclusion, the PPCD interpretative framework developed in this study, describes the status of black men at the PPCD, their experiences during the PPCD, and their needs at the PPCD. The framework provides information that can be used by physicians to prepare for their PPCD consultation with black men as well as develop a support system for black men at the PPCD. Cancer fatalism Participant 2128 (CBBM) It was just a question of-I was just being fatalist about it you know. It's one of these things that happens and I was fortunate that it was immediately diagnosed and treatment could be organized.
Participant 2024 (CBBM) Because, um, although I knew that prostate cancer, um, had the best chance of being cured of all the cancers, when the doctor told me I had prostate cancer, I did not hear prostate, I heard cancer. The big C. And my brother, um, my younger brother died, um, back in 2006 from, um, colon cancer, so that was-it was that close to me because I was diagnosed most about five years ago. So it was that close to me, the memory of him, I only heard cancer. Thoughts about impact on manhood
Participant 486 (NBBM)
What effect it would have on me, from being a male, you know, I feared rumors that-I had heard rumors that it would take your manhood away from you and everything about it. That you would never be the same.
Questioning/ exploring reasons
Participant 1261 (CBBM) Um, you know, I was-I was just curious, you know, "What is it? Is it something I ate? Is it-is it the environment?" Or, you know, just-just kind of started looking at my lifestyle. I know like-but I never-I mean, I don't drink alcohol. I don't smoke. Um, in fact, I used to-did not detest people who smoke, but hate being around smoke and all that kind of stuff, so-and alcohol and stuff like that. I-and I-I thought I ate pretty healthy, so I was curious. "Man, you know, how did-how did I get this?" Participant 847 (NBBM) I was shocked, scared, worried, you know, all of that. It-it kind of-it kind of flipped me. I didn't know how-how bad it was or nothing, but he told me it wasn't that bad, but I need to go in and get rid of it.
Hope Participant 355 (NBBM) And I remember I read about ____ ____, the _____ ____ ____, has prostate, and it was treated, and he's still living. Uh,_______ has prostate. He was treated and is-and is living. And I think, uh, ________, uh, uh, _______, ________ ______, the black guy, has prostate. He was treated and is living. So that kind of gave me some confidence that if I get a very good treatment, the end has not come.
Fear
Participant 1822 (NBBM) Oh, it scared me a little bit then. You know?
Participant 2128 (CBBM) Well, initially, there was a feeling of trepidation, fear, and disbelief, not knowing what to expect. Not knowing what was involved in the treatment. As I said, the only information or evidence that I could draw on was what my wife experienced when she was going through chemo and radiation treatment and I just hoped that it would not be as severe, at least at the outset. That the treatment would not be as severe to me as it was to her. Unfortunately, that was not the case.
Participant 2024 (CBBM) Um, and it was scary when I was told I had prostate cancer, quite frankly.
Participant 1594 (NBBM) And, um-it was a cold moment, okay?
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Fight/resilience Participant 866 (CBBM) Well, the first thing that comes to one's mind when they hear the-the big letter C is that, "Oh, man. This is a journey. It's a journey that can either put you in the grave or it's a journey that you're just gonna have to fight vigorously, but your life is basically changed." And so I had to look at it-I'm a-as-as-if-if it's was gonna kill me, I gotta go down fightin' with it. But it does change your life.
Participant 1970 (NBBM) And I think the most important thing about it is reading, getting information. Knowledge about prostate was the thing that, um, kinda brought me around to, "I can beat this."
Participant 847 (NBBM) Well, they kind of had me worried there for a minute. I didn't know what to expect or what to do, but I still-I felt good. I mean, you know, it's-you know, it's-it was just-just like a normal life. I-but I just knew I had this cancer and I had to get it out.
Participant 449 (NBBM) Um, nothing negative. Uh, it-fear was not, um, an emotion that I experienced when I got the diagnosis. Um, my only, uh, thought, I think, was, uh, how do I-how do I take care of this? You know, how do I cure myself?
Participant 449 (NBBM) Um, I knew that there was nothing that I had done that caused the disease. You know, I-I-it just-I just happened to be the one that-that had the prostate cancer. Um, my only concern was, you know, uh, uh, curing. You know, how do I recover from this and-and live another 50 or 60 years?
Need for immediate action/urgency Participant 975 (CBBM) Then I se-go there. Then, uh, when they start to do the test thing like that, then, uh, they tell me, "Yes, definitely you have." I-I say, "How big? How fast is it?" They say, "Well, is not that sudden on you." But, uh, they're goin' look at it, and at three months a level, uh-uh, how fast is-is grow. Participant 1263 (CBBM) I didn't feel nothing. I didn't broke down nothing at all. I was have faith and I was going through with it.
Will to live Participant 527 (NBBM) First thing that came to mind: I don't want it to cut my life short. I want to go ahead and live a full life. I wanted to go ahead on and be able to do the kinda things that I used to do and-and-and enjoy. Uh, I didn't wanna leave my wife, uh, you know, early. You know? If I go a natural death, then I can't do anything about that, but if I can prevent leaving early by taking care of myself and going and get the-the necessary, uh, uh, medication, the necessary, uh, uh, surgery, or the necessary treatment to prevent me from passing early. It-it gave me the long longevity that I-I-I expected to receive.
Behavior
Delay taking action Participant 1594 (NBBM) But what happened when I was diagnosed, I said, okay. Um, I just couldn't believe it. And it took me maybe two or three months to go to the treatment center. And when I got to the treatment center, um, I saw on the sign, cancer, and I got back in the car before I went in the building. Okay. God. It's saying cancer. I finally got enough nerve to get up and go back in, and I sat there.
Expressed needs
Need to be comfortable with physician Participant 1594 (NBBM) I didn't know who to talk to. …. and it was this doctor-not calling any name-that I ran into, and he was of color, like I was. So I came to the office and got on the computer and typed this in and said, "I need to talk to somebody." And this doctor said, "Well, you can come in and talk to me." He reserved two hours just for me and him to talk. And, um, he discussed-I-I got my own-I brought the-the medical record with me. I made sure. … I'm saying, lots of time, we don't know who to talk to. There's no one to talk to, so we're embarrassed. But I just happened to-to know this doctor-... and we became friends. And he took me in and said, "Well, look, my auntmy uncle had it. My brother have it, so don't be embarrassed." So he made me comfortable.
